152 related articles for article (PubMed ID: 6669479)
41. Antibody response of mice to chemically induced tumors.
Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
[TBL] [Abstract][Full Text] [Related]
42. Effect of vitamin E as an immunopotentiation agent and its influence on tumor growth in mice.
Yasunaga T; Ohgaki K; Inamoto T; Kan N; Kikasa Y
Nihon Geka Hokan; 1984 Mar; 53(2):312-23. PubMed ID: 6508461
[No Abstract] [Full Text] [Related]
43. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
[TBL] [Abstract][Full Text] [Related]
44. Increased resistance in splenectomized mice to a methylcholanthrene-induced tumour.
Chang RW; Turk JL
Br J Cancer; 1977 Jun; 35(6):768-76. PubMed ID: 871366
[TBL] [Abstract][Full Text] [Related]
45. Cellular immune responses to methylcholanthrene-induced fibrosarcoma in BALB/c mice.
Bhatnagar RM; Zabriskie JB; Rausen AR
J Exp Med; 1975 Oct; 142(4):839-55. PubMed ID: 1185107
[TBL] [Abstract][Full Text] [Related]
46. Changes in cellular composition induced by neocarzinostatin pretreatment in Meth A-bearing mice and the responsible antitumor effector cells.
Masuda E; Shishido T; Fujimoto R; Maeda H
Immunopharmacology; 1997 Aug; 37(1):105-16. PubMed ID: 9285249
[TBL] [Abstract][Full Text] [Related]
47. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
Hellström KE; Hellström I
Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
[TBL] [Abstract][Full Text] [Related]
48. In vivo tumor growth enhancement by granulocyte colony-stimulating factor.
Segawa K; Ueno Y; Kataoka T
Jpn J Cancer Res; 1991 Apr; 82(4):440-7. PubMed ID: 1710615
[TBL] [Abstract][Full Text] [Related]
49. The difference in immunological properties between lymph node metastatic and non-metastatic cell lines of MCA-induced fibrosarcoma of C4W mice.
Oguri H; Sato Y; Sugawara H; Yoshida K; Nishihira T; Mori S; Tachibana T
Tohoku J Exp Med; 1992 Oct; 168(2):409-12. PubMed ID: 1306327
[TBL] [Abstract][Full Text] [Related]
50. Protective effect of vitamin E against immunosuppression induced by adriamycin, mitomycin C and 5-fluorouracil in mice.
Yasunaga T; Ohgaki K; Inamoto T; Kan N; Hikasa Y
Nihon Geka Hokan; 1983 Sep; 52(5):591-601. PubMed ID: 6426418
[No Abstract] [Full Text] [Related]
51. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.
Ebina T; Murata K
Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151
[TBL] [Abstract][Full Text] [Related]
52. Host-mediated antitumor activity of Lactobacillus casei in mice.
Yasutake N; Kato I; Ohwaki M; Yokokura T; Mutai M
Gan; 1984 Jan; 75(1):72-80. PubMed ID: 6427051
[TBL] [Abstract][Full Text] [Related]
53. Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.
Ebina T; Murata K
Jpn J Cancer Res; 1991 Nov; 82(11):1292-8. PubMed ID: 1752785
[TBL] [Abstract][Full Text] [Related]
54. Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors.
Bursuker I; North RJ
Cancer Immunol Immunother; 1985; 19(3):215-8. PubMed ID: 3159472
[TBL] [Abstract][Full Text] [Related]
55. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
Ebina T; Kohya H; Ishikawa K
Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
[TBL] [Abstract][Full Text] [Related]
56. Non-H-2-linked genetic control of resistance to BALB/c fibrosarcoma Meth-A.
Mizushima Y; Sendo F; Takeichi N; Kobayashi H
J Immunogenet; 1980 Dec; 7(6):447-53. PubMed ID: 7240765
[TBL] [Abstract][Full Text] [Related]
57. Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo.
Busund LT; Killie MK; Bartnes K; Seljelid R
Int J Cancer; 2003 Aug; 106(2):153-9. PubMed ID: 12800188
[TBL] [Abstract][Full Text] [Related]
58. [Host mediated anti-tumor effect of Nocardia rubra cell wall skeleton on syngeneic tumor in mice].
Hirai O; Fujitsu T; Oku R; Satoh H; Shimomura K; Ennyu K; Senoh H; Mori J; Kikuchi H
Nihon Yakurigaku Zasshi; 1987 May; 89(5):307-16. PubMed ID: 3497852
[TBL] [Abstract][Full Text] [Related]
59. Diffusible cytotoxic substances and cell-mediated resistance to syngeneic tumors: in vitro demonstration.
Kikuchi K; Reiner J; Southam CM
Science; 1968 Jul; 165(3888):77-9. PubMed ID: 5729682
[No Abstract] [Full Text] [Related]
60. Production of T-cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report.
Mulé JJ; Forstrom JW; George E; Hellström I; Hellström KE
Int J Cancer; 1981 Nov; 28(5):611-4. PubMed ID: 6796530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
